MCMU
NMRA icon

MIC Capital Management (UK)’s Neumora Therapeutics NMRA Stock Holding History

MIC Capital Management (UK)’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.7M Hold
4,460,700
– – 2.47% 9
2025
Q4 		$7.98M Hold
4,460,700
– – 1.81% 11
2025
Q3 		$8.12M Hold
4,460,700
– – 1.62% 11
2025
Q2 		$3.27M Hold
4,460,700
– – 0.64% 12
2025
Q1 		$4.46M Hold
4,460,700
– – 0.91% 13
2024
Q4 		$47.3M Hold
4,460,700
– – 6.69% 4
2024
Q3 		$58.9M Hold
4,460,700
– – 8.18% 3
2024
Q2 		$43.8M Hold
4,460,700
– – 9.53% 3
2024
Q1 		$61.3M Hold
4,460,700
– – 11.65% 3
2023
Q4 		$76.1M Hold
4,460,700
– – 14.76% 3
2023
Q3 		$62.9M Buy
+4,460,700
New +$55.7M 14.35% 3

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MIC Capital Management (UK)'s NMRA Position: Q1 2026 in Review

MIC Capital Management (UK) held its Neumora Therapeutics (NMRA) position steady in Q1 2026 at 4,460,700 shares worth $8.7M. The position accounts for 2.47% of the portfolio, ranked #9.

MIC Capital Management (UK) first reported a position in NMRA in Q3 2023 and has held it in 11 quarters since. The position peaked at $76.1M in Q4 2023. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

  • MIC Capital Management (UK) held 4,460,700 shares of Neumora Therapeutics worth $8.7M as of Q1 2026.
  • MIC Capital Management (UK) left its Neumora Therapeutics share count unchanged in Q1 2026.
  • Neumora Therapeutics made up 2.47% of MIC Capital Management (UK)'s portfolio in Q1 2026, its #9 holding.
  • MIC Capital Management (UK) first reported a position in Neumora Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • MIC Capital Management (UK)'s Neumora Therapeutics position peaked at $76.1M in Q4 2023.
  • 114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on MIC Capital Management (UK)'s 13F filing for Q1 2026, filed 13 May 2026.